Trial site
Medifarma-98 Kft.
- 15running trials
- 13closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Heart failure8 trials
- Obesity6 trials
- Type 2 diabetes6 trials
- Chronic kidney disease5 trials
- Atrial fibrillation3 trials
- High blood pressure3 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Obstructive sleep apnoea1 trial
- Osteoarthritis1 trial
- Phase
- Phase 321 trials
- Phase 27 trials
- Status
- Completed13 trials
- Active, not recruiting6 trials
- Not yet recruiting5 trials
- Recruiting4 trials
- Lead sponsor
- AstraZeneca8 trials
- Eli Lilly and Company4 trials
- Anthos Therapeutics, Inc.2 trials
- Hoffmann-La Roche2 trials
- Ionis Pharmaceuticals, Inc.2 trials
- and 9 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Obesity3 recruiting
- Type 2 diabetes3 recruiting
- Chronic kidney disease2 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Terminated
Completed
Completed
Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026